Cargando…
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Diabetes is a highly prevalent metabolic disease that has emerged as a global challenge due to its increasing prevalence and lack of sustainable treatment. Diabetic kidney disease (DKD), which is one of the most frequent and severe microvascular complications of diabetes, is difficult to treat with...
Autores principales: | Fang, Qing, Liu, Na, Zheng, Binjie, Guo, Fei, Zeng, Xiangchang, Huang, Xinyi, Ouyang, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173181/ https://www.ncbi.nlm.nih.gov/pubmed/34093430 http://dx.doi.org/10.3389/fendo.2021.636175 |
Ejemplares similares
-
Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
por: Fang, Qing, et al.
Publicado: (2021) -
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
por: Zixin, Ye, et al.
Publicado: (2022) -
Gut Microbiota Modulates the Protective Role of Ginsenoside Compound K Against Sodium Valproate-Induced Hepatotoxicity in Rat
por: Zhou, Luping, et al.
Publicado: (2022) -
The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023) -
Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
por: Wang, Dongmei, et al.
Publicado: (2022)